Loading news...
In the closing of the recent trading day, Synopsys (SNPS) stood at $525.34, denoting a +2.11% move from the preceding trading day.
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock?
D.A. Davidson and CO. boosted its holdings in Synopsys, Inc. (NASDAQ: SNPS) by 30.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,715 shares of the semiconductor company's stock after buying an additional 1,346 shares during the period. D.A. Davidson and
In the most recent trading session, Synopsys (SNPS) closed at $514.49, indicating a -1% shift from the previous trading day.
First Merchants Corp purchased a new position in shares of Synopsys, Inc. (NASDAQ: SNPS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,045 shares of the semiconductor company's stock, valued at approximately $4,956,000. Several other institutional investors
APS Management Group Inc. bought a new position in shares of Synopsys, Inc. (NASDAQ: SNPS) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 61,481 shares of the semiconductor company's stock, valued at approximately $30,334,000. Synopsys makes up 21.2% of
Synopsys solutions accelerate innovation from systems to silicon, enabling more than 90% of the top 100 automotive suppliers to boost engineering productivity, predict system performance, and deliver safer, more sustainable mobility Key Highlights Synopsys will support the Fédération Internationale de l'Automobile (FIA), the global governing body for motorsport and the federation for mobility organizations worldwide, to enhance single-seater safety standards Ansys AVxcelerate Sensors™ software now includes the Samsung ISOCELL Auto 1H1 automotive image sensor to simulate performance with high fidelity under real-life conditions Synopsys Virtualizer™ Developer Kits for customers' latest automotive SoCs enable system bring-up within days of silicon availability and accelerate vehicle time to market by up to 12 months SUNNYVALE, Calif., Jan. 6, 2026 /PRNewswire/ -- Synopsys, Inc. (NASDAQ: SNPS) is showcasing AI-driven and software-defined engineering solutions this week at CES that tackle one of the industry's biggest challenges: accelerating automotive engineering innovation in the age of AI while reducing cost and complexity.
The acquisition of Ansys is a game-changer for Synopsys, opening new markets and attracting new customers. Nvidia's computing power will be a key feature of the company's overall solutions.
Stanley Laman Group Ltd. grew its position in Synopsys, Inc. (NASDAQ: SNPS) by 542.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,877 shares of the semiconductor company's stock after purchasing an additional 10,874 shares during the period.
The latest trading day saw Synopsys (SNPS) settling at $480.42, representing a +2.28% change from its previous close.
CMH Wealth Management LLC increased its position in shares of Synopsys, Inc. (NASDAQ: SNPS) by 42.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,299 shares of the semiconductor company's stock after buying an additional 4,575 shares during the
Ascent Group LLC lifted its stake in Synopsys, Inc. (NASDAQ: SNPS) by 67.1% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,804 shares of the semiconductor company's stock after acquiring an additional 1,126 shares during the period. Ascent
Calamos Wealth Management LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ: SNPS) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 21,555 shares of the semiconductor company's stock, valued at approximately $10,635,000. Other hedge funds also recently modified their holdings of
PHILADELPHIA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Synopsys, Inc. ("Synopsys, Inc." or the "Company") (NASDAQ: SNPS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Synopsys, Inc. investors who were adversely affected by alleged securities fraud between December 4, 2024 and September 9, 2025.
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4,
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Synopsys, Inc. ("Synopsys, Inc." or the "Company") (NASDAQ: SNPS) of a class action securities lawsuit.
/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS)
New York, New York--(Newsfile Corp. - December 29, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.
LOS ANGELES, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.